Patent foramen ovale (PFO) is associated with cryptogenic stroke in young patients. In these cases, trans-catheter PFO closure is indicated either with a device implantation or with a suture-mediated PFO closure system (NobleStitchTM EL, Kardia, Milan, Italy) to prevent further cerebral ischemic events. However, the presence of a complex anatomy might require advanced technical skills. We herewith describe the first case of combined use of the NobleStitchTM EL system with an Amplatzer PFO Occluder (Abbott, Plymouth, USA) device to close a complex PFO characterized by a wide inter-atrial aneurysm, a long stiff tunnel and a thickened septum secundum.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Canadian Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.Eur Heart J Cardiovasc Imaging. 2014; 15: 1377-1385
- PFO “angioplasty”: The preparation of a very stiff and long tunnel for device closure.Catheter Cardiovasc Interv. 2017; 89: 480-483
- Use of balloon pull-through technique to assist in CardioSEAL device closure of patent foramen ovale.Catheter Cardiovasc Interv. 2003; 60: 101-106
- Transseptal puncture to facilitate device closure of “long-tunnel” patent foramen ovale.Catheter Cardiovasc Interv. 2015; 85: 1053-1057
- Anatomic Approach to Transseptal Puncture for Structural Heart Interventions.JACC Cardiovasc Interv. 2021; 14: 1509-1522
Accepted: February 8, 2023
Received in revised form: February 2, 2023
Received: January 11, 2023
Publication stageIn Press Journal Pre-Proof
© 2023 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.